2019 Insurance M&A outlook

March 1, 2019

The stage is set for the continuation of an active insurance industry M&A environment in 2019. Sustained US economic growth, rising interest rates, and higher investment income are among the positive factors bolstering insurance companies’ results in 2018 and positioning them for enhanced top- and bottom-line growth in 2019.

Spotlight

Elabscience

Elabscience specializes in immunodiagnostic technology for life science community. We have complete platform for R&D and manufacture. Our in house QC for every product keep your experiment results more consistent and precise. Elabscience major products cover recombinant proteins, peptides, FCM antibodies, antibodies, ELISA kits, biochemical kits, labeling kits, chromatographic media, cell line, cell culture products, and many more.

OTHER WHITEPAPERS
news image

Automating insurance reconciliations: Challenges and opportunities for 2022

whitePaper | April 21, 2022

Progress in the areas of robotics, Artificial Intelligence (AI) and Machine Learning (ML) continues to define a new era of automation in finance. In the last decade, one such focus area for many financial organisations has been automating and modernising key back-office processes like reconciliations. Yet the insurance industry has lagged behind in this regard, relying on outdated reconciliation procedures far longer than any other financial sector. The result is that many firms today struggle with critical issues like differing data formats, manual processes and IT dependencies.

Read More
news image

A 3-Step Guide to Insurance Transformation

whitePaper | March 2, 2020

The insurance industry is operating in an age of radical disruption. Traditional insurers are no longer safe, with insurtechs challenging incumbents to rethink their business and operating models. The diversification of product offerings and ever-growing price competitiveness mean that customer expectations are changing faster than ever before.

Read More
news image

A digital divide?

whitePaper | February 24, 2020

Commercial property insurance providers find themselves operating in unpredictable conditions, with political and economic uncertainty having negative impacts on business activity in almost every industry. The retail sector is under particular pressure, but there are also significant problems in the o-ice buildings market, as businesses postpone expansion or investment plans, and some consider relocating facilities outside the UK once (or if) the Brexit process is completed.

Read More
news image

A Changing D&O Environment in EMEA: More Volatility Ahead?

whitePaper | July 3, 2022

The D&O insurance market over the past decade experienced rate reductions, broadening coverage and increasing claims frequency and severity. This meant that losses outpaced premiums and the industry needed to respond. The magnitude and speed of the response that followed surprised many market participants. Significant capacity shortage led to sharp price increases and in many cases to reduced limits purchased by companies. The outlook for the D&O market remains challenging as the risk environment is more uncertain than ever.

Read More
news image

Customer Centricity in Insurance

whitePaper | August 25, 2022

From climate change to Covid-19, shifting customer demand to ever-evolving regulatory compliance, the challenges are ongoing and today present some of the biggest barriers to success faced by the insurance industry. The sheer amount of upheaval has been unprecedented, and its pace is only accelerating. It comes as no surprise that as a result, 64% of global insurance CEOs plan to significantly increase their digital transformation investment over the next three years.

Read More
news image

The past, present and future of AI in insurance

whitePaper | October 20, 2022

The pervasiveness of examples of AI in popular culture clearly illustrates that we humans are fascinated with the idea of artificial intelligence and its various transformative implications. Just imagine a world of computers with consciousness, robots with feelings and everything in between. And while Hollywood’s perspective on AI typically leans toward the fantastic, it represents an interesting parallel to the business world. From the boardroom to the shop floor, there is a rapidly growing interest in AI’s potential to transform the very way we do business. The insurance industry is no different, and in many ways is an ideal candidate for transformation driven by artificial intelligence.

Read More

Spotlight

Elabscience

Elabscience specializes in immunodiagnostic technology for life science community. We have complete platform for R&D and manufacture. Our in house QC for every product keep your experiment results more consistent and precise. Elabscience major products cover recombinant proteins, peptides, FCM antibodies, antibodies, ELISA kits, biochemical kits, labeling kits, chromatographic media, cell line, cell culture products, and many more.

Events